Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Nath Bio-Genes (India) Limited has informed the Exchange about General Updates Investor Presentation on financial Results as on 31st December 2025more...
Investor Presentation of Financial Results as on 31st December 2025more...
Nath Bio-Genes (India) Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Nath Bio-Genes (India) Limited has informed the Exchange about Loss of Share Certificatesmore...
The company reported standalone net profit of Rs 7.23 crore for the quarter ended December 31 2025 as compared to Rs 2.66 crore in the same period la...more...
Financial Results as on 31st December 2025.more...
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to conside...more...
As of December 2025 45.59% is owned by Indian Promoters and 54.40% by Public. Top five Promoters holding highest number of shares of Nath Bi...more...
Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Compliance Certificate under Reg 74more...
Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regul...more...
Nath Bio-Genes (India) Limited has informed the Exchange regarding Transcript of concall .more...
Earning Call Transcriptmore...
Nath Bio-Genes (India) Limited has informed the Exchange regarding Presentation on financial results .more...
Investor Presentation on financial results as on 30th September 2025.more...
The company reported standalone net profit of Rs 4.20 crore for the quarter ended September 30 2025 as compared to Rs 2.89 crore in the same...more...
Nath Bio-Genes (India) Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
Outcome of Board Meetingmore...
Unaudited Financial Results as on 30th September 2025more...
Nath Bio-Genes (India) Limited has informed the Exchange regarding .more...
BOARD MEETINGS Company Name : Aadhaar Ventures Ind Date : 20-03-2026